ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Novo Nordisk (PK)

Novo Nordisk (PK) (NONOF)

41.70
0.45
(1.09%)
終了 6月10日 5:00AM

Novo Nordisk (PK) (NONOF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
41.70
( 1.09% )
買値
40.75
売値
42.66
出来高
4,270
40.215 日の範囲 41.8625
34.00 52 週間の範囲 82.496
時価総額
前日終値
41.25
始値
40.215
最終取引時間
財務取引量
US$ 177,347
VWAP
41.5333
平均取引量 (3 か月)
US$ 6,163,492
発行済株式数
4,432,851,022
配当利回り
11.7 (4.03%)
PER
10.36
1 株当たり利益 (EPS)
27.41
歳入
327.8B
純利益
121.96B

Novo Nordisk (PK) について

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, ob... Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Bagsvaerd, Denmark
設立
2026
Novo Nordisk (PK) is listed in the Healthcare sector of the その他OTC with ticker NONOF. The last closing price for Novo Nordisk (PK) was US$41.25. Over the last year, Novo Nordisk (PK) shares have traded in a share price range of US$ 34.00 to US$ 82.496.

Novo Nordisk (PK) currently has 4,432,851,022 shares in issue. The market capitalisation of Novo Nordisk (PK) is US$184.85 billion. Novo Nordisk (PK) has a price to earnings ratio (PE ratio) of 10.36.

NONOF 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.671.632951498941.0345.189940.2151108043.11405806CS
4-2.8601-6.4185224000844.560147.849940.2151222544.33383365CS
122.43016.1882001227439.269948.34853419823436.5797471CS
26-3.87-8.4924292297645.5764.753417641942.96345576CS
52-31.81-43.273024078473.5182.4963422504950.10991534CS
156-118.38-73.9505247376160.08201.983411116366.80200314CS
260-42.41-50.422066341784.11201.98347447672.11051444CS

NONOF - Frequently Asked Questions (FAQ)

What is the current Novo Nordisk (PK) share price?
The current share price of Novo Nordisk (PK) is US$ 41.70
How many Novo Nordisk (PK) shares are in issue?
Novo Nordisk (PK) has 4,432,851,022 shares in issue
What is the market cap of Novo Nordisk (PK)?
The market capitalisation of Novo Nordisk (PK) is USD 184.85B
What is the 1 year trading range for Novo Nordisk (PK) share price?
Novo Nordisk (PK) has traded in the range of US$ 34.00 to US$ 82.496 during the past year
What is the PE ratio of Novo Nordisk (PK)?
The price to earnings ratio of Novo Nordisk (PK) is 10.36
What is the cash to sales ratio of Novo Nordisk (PK)?
The cash to sales ratio of Novo Nordisk (PK) is 3.84
What is the registered address of Novo Nordisk (PK)?
The registered address for Novo Nordisk (PK) is Novo Alle 1, Bagsvaerd, Capital Region of Denmark, 2880
What is the Novo Nordisk (PK) website address?
The website address for Novo Nordisk (PK) is www.novonordisk.com
Which industry sector does Novo Nordisk (PK) operate in?
Novo Nordisk (PK) operates in the Biotechnology & Life Sciences sector

NONOF 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード